Rare Disease Families Gain Tools for Drug Development Through Ultragenyx Bootcamps
Families of children with rare diseases are increasingly taking the lead in developing treatments, often with the help of programs like Ultragenyx’s Rare Bootcamp. These initiatives provide guidance on navigating the complex drug development process, connecting families with researchers and clinicians. This trend is accelerating progress in the rare disease space, despite the high costs and long timelines typically associated with drug development.
Tickers: $RARE
Topics: biotech drug development medical innovation patient advocacy rare diseases